This content is for informational purposes only. CGM devices are not diagnostic tools. Always consult your healthcare provider before making health decisions. CGM data in people without diabetes should not be used to self-diagnose any condition.
Device information comes from published accuracy data, FDA clearance documents and manufacturer documentation.
What does a CGM actually show without diabetes?
CGMs estimate interstitial glucose. Display intervals differ: original Libre 3 every minute, G7 every five minutes, and Stelo app display every fifteen minutes despite five-minute sensor transmission. Research observations in healthy people are not personal diagnostic thresholds.
What CGM data shows non-diabetic users includes how quickly glucose rises after different foods, how exercise affects glucose patterns, how stable overnight glucose is, and what the dawn phenomenon looks like on a personal basis. All of this is device data — readings from a sensor. What any individual pattern means is a question for a healthcare provider.
The Dexcom Stelo and Abbott Lingo are over-the-counter continuous glucose monitors that the FDA has cleared as medical devices (Stelo, FDA K234070 and Lingo, FDA K233655). Their FDA indication is for adults aged 18 and older (Lingo) or people aged 2 years and older (Stelo, since June 2026) who do not use insulin; that group includes people without diabetes but also people with diabetes who do not use insulin, so it is not specific to people without diabetes. The readings are informational: medical decisions based on them should be made after consulting a qualified healthcare professional. The Stelo is also not intended for people with problematic hypoglycemia or on dialysis.
See what OTC devices cost for 30, 90, or 365 days.
CGMs available without a prescription in 2026
Stelo and Lingo are the two OTC devices compared here. FDA also cleared Libre Rio (K233861), which does not establish its current commercial availability. Dexcom Stelo is an over-the-counter device for people aged 2 years and older who do not use insulin, with caregiver supervision below 18. It is not intended for problematic hypoglycemia or dialysis and has no clinical high/low alarms. Platform enrollment may have narrower eligibility. Lingo is for adults 18 years and older not using insulin.
| Device | Monthly cost | Sensor life | MARD | App style |
|---|---|---|---|---|
| Abbott Lingo | Check price | 14 days | 8.1–10.7% (by glucose range) | Lingo Count plus glucose graph |
| Dexcom Stelo | Check price | 15 days | 7.3–9.1% (historical adults, by wear period) | Full data graph |
Prescription CGMs require a prescription. The OTC options above can be purchased without one; purchase availability does not establish individual suitability.
Abbott Lingo — for non-diabetics
Abbott Lingo — no prescription
Abbott Lingo is built on the FreeStyle Libre platform — its sensor is based on the FreeStyle Libre 2 (FDA K233655) — with pricing set by Abbott. The Lingo app adds up identified glucose spikes into a daily Lingo Count and also displays a glucose graph. The Count is a proprietary score, not a clinical health target.
As an Amazon Associate we earn from qualifying purchases. Some links on this page are affiliate links.
Dexcom Stelo — OTC glucose monitoring
Dexcom Stelo — no prescription
Stelo supports up to 15-day wear. Its app updates glucose display every fifteen minutes; it has no clinical high/low alarms. Check current logging, Clarity and sharing functions with Dexcom rather than inferring clinical superiority. Follow the separate OTC indication and exclusions.
Our free calculator shows costs for any monitoring period.
Is a CGM worth it without diabetes?
A CGM produces sensor glucose observations. Interpreting patterns requires clinical context; engagement with a trace does not by itself establish a health benefit.
Logging foods, workouts and sleep alongside sensor readings can describe associations in an individual record. Engagement with those observations does not establish a health benefit; discuss interpretation with a qualified healthcare professional.
Check Abbott and Dexcom for current pricing. A wear limit or package size does not establish an appropriate monitoring duration or clinical benefit; discuss whether there is a useful monitoring question.
A provider can help assess whether CGM answers a useful question and how to interpret observations. This page establishes neither cost-effectiveness nor a clinical benefit for routine use without diabetes.
Questions about CGM without diabetes
Active people tracking fueling and recovery
Athletes and active users use CGMs to observe how training sessions, carbohydrate timing, and recovery periods appear in glucose data. See our CGM for athletes guide for device-specific recommendations.
People tracking intermittent fasting
CGMs show what glucose patterns look like during fasting windows — how stable overnight glucose is, and how it changes when eating resumes. See our CGM for intermittent fasting guide for more detail.
Users with prediabetes awareness
People who have been told they have elevated blood sugar sometimes use CGMs to observe how dietary choices appear in their glucose data. This is informational — not a treatment. Always work with your healthcare provider if you have specific concerns about blood sugar levels.
Curious, data-oriented users
Many non-diabetic CGM users are simply curious about their metabolic data. The quantified-self community has used CGMs for years. For data-oriented users willing to engage with the graph, CGM data can be of interest even without a specific goal.
Options for people without diabetes
Adults 18+ not on insulin; over the counter (Lingo); People not on insulin; FDA-cleared from age 2 (June 2026) (Stelo). Dexcom Stelo's and Lingo's published MARD ranges (7.3–9.1% (historical adults, by wear period) and 8.1–10.7% (by glucose range)) come from separate manufacturer studies and are not directly comparable, so they do not show which device is more accurate for you. Nutrisense lists dietitian coaching as a separate service.
See Lingo vs Stelo vs Levels for any monitoring period.
Affiliate link. See our disclosure.
Ultrahuman's app, scores and coaching on top of third-party Abbott Lingo biosensors, delivered monthly. Ships to US addresses only; an NFC-enabled phone is needed to activate each sensor.